Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IB Pancreatic Adenocarcinoma”

94 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 94 results

Testing effectiveness (Phase 2)WithdrawnNCT03908333
What this trial is testing

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Medical College of Wisconsin
Not applicableEnded earlyNCT04476537
What this trial is testing

RNA Precision Oncology in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Columbia University 16
Early research (Phase 1)Study completedNCT02501902
What this trial is testing

Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Pfizer 76
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Early research (Phase 1)Study completedNCT01764477
What this trial is testing

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic CancerMetastatic Pancreatic CancerPancreatic Adenocarcinoma
Prism Pharma Co., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT07284277
What this trial is testing

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)

Who this might be right for
Pancreatic Adenocarcinoma MetastaticPancreatic Ductal Adenocarcinoma
Clinica Universidad de Navarra, Universidad de Navarra 30
Testing effectiveness (Phase 2)Ended earlyNCT01562899
What this trial is testing

MEK162 and AMG 479 in Patients With Selected Solid Tumors

Who this might be right for
Metastatic Pancreatic AdenocarcinomaBRAF Mutated Melanoma
Pfizer 77
Early research (Phase 1)Ended earlyNCT01192763
What this trial is testing

RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage IA Pancreatic CancerStage IB Pancreatic Cancer+2 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT03373188
What this trial is testing

VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer

Who this might be right for
Colon Carcinoma Metastatic in the LiverColorectal AdenocarcinomaPancreatic Adenocarcinoma+11 more
Emory University 10
Early research (Phase 1)Study completedNCT01010945
What this trial is testing

Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
OSI Pharmaceuticals 19
Early research (Phase 1)Looking for participantsNCT06896188
What this trial is testing

9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)

Who this might be right for
Pancreatic Adenocarcinoma
Anwaar Saeed 12
Testing effectiveness (Phase 2)Study completedNCT00609336
What this trial is testing

Perioperative Therapy for Resectable Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage IA Pancreatic CancerStage IB Pancreatic Cancer+2 more
University of Washington 35
Testing effectiveness (Phase 2)WithdrawnNCT02575508
What this trial is testing

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Who this might be right for
Colon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT01234935
What this trial is testing

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+5 more
Translational Oncology Research International 8
Early research (Phase 1)Ended earlyNCT05417386
What this trial is testing

FOLFIRINOX + NIS793 in Pancreatic Cancer

Who this might be right for
Pancreas CancerMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma
Colin D. Weekes, M.D., PhD 4
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Testing effectiveness (Phase 2)WithdrawnNCT01473303
What this trial is testing

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology
Early research (Phase 1)Ended earlyNCT01233505
What this trial is testing

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adenocarcinoma of the PancreasAdenocarcinoma of the StomachBRCA1 Mutation Carrier+23 more
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT03269526
What this trial is testing

BATs Treatment for Pancreatic Cancer, Phase Ib/II

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic Adenocarcinoma
University of Virginia 22
Early research (Phase 1)Study completedNCT02077933
What this trial is testing

Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors

Who this might be right for
NeoplasmsBreast NeoplasmsKidney Neoplasms+1 more
Novartis Pharmaceuticals 79
Load More Results